Generation of Reactive Oxygen Species in Peripheral Blood Lymphocytes of Patients with Prostate Cancer


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The study revealed a two-fold elevation of ROS production in peripheral blood lymphocytes of the patients with prostate cancer (from 0.48±0.04 to 0.93±0.12 rel. units) together with significant variability of individual values. Hormone therapy had no effect on the mean and individual ROS levels. In contrast, organometallic cytostatics cisplatin and morfozol 2-fold increased ROS generation in lymphocytes of patients with prostate cancer above the enhanced level of this parameter determined by tumor growth.

About the authors

A. K. Grekhova

N. M. Emanuel Institute of Biochemical Physics, Russian Academy of Sciences

Author for correspondence.
Email: annagrekhova1@gmail.com
Russian Federation, Moscow

L. B. Gorbacheva

N. M. Emanuel Institute of Biochemical Physics, Russian Academy of Sciences

Email: annagrekhova1@gmail.com
Russian Federation, Moscow


Copyright (c) 2016 Springer Science+Business Media New York

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies